Today in this blog we will try to know Alkem Share Price Target 2025, 2026, 2027, To 2030 In this blog we are going to analyze the stock Alkem Laboratories Ltd of the Pharmaceuticals sector. In this blog we will do all the research of the company for you like what does the company do? How can the performance of the company be for 5 years? Future status of the company? You will find information about all this research in this blog.
After reading this blog, you will also get to know about the technical analysis along with fundamentals about Alkem Laboratories Ltd. From which you can find out whether you should invest in this company or not, so let’s try to know the company.
About Alkem Laboratories Ltd
Alkem Laboratories is a leading Indian pharmaceutical company that works to improve the health of people in India and around the world. The company has a strong product portfolio and is constantly working to expand into new products and markets.
Alkem Laboratories manufactures medicines to treat a variety of diseases. These medicines include pain relievers, antibiotics, heart disease medicines, and diabetes medicines. The company sells its medicines not only in India but also in many other countries.
Alkem Laboratories was founded in 1973 and is headquartered in Mumbai, India.
| Company Name | Alkem Laboratories Ltd |
| Market Cap | ₹ 65,554 Cr. |
| P/E | 30.2 |
| ROE (Return on equity) | 19.6 % |
| ROCE (Return on Capital Employed ) | 19.7 % |
| 52 Week High (13-Sep-2024) | ₹ 6,439.90 |
| 52 Week Low (04-Jun-2024) | ₹ 4,407.05 |
| DIV. YIELD | 0.73 % |
| Date of Listing | 23-Dec-2015 |
Alkem last 5 Year Performance
If we talk about the returns of Alkem Laboratories Ltd (ALKEM) share in the last few years, then the company has given 6.00% returns to its investors in the last 1 year (Dec 2023 – Dec 2024). And if we talk about 5 years, then it has given 173.41% returns to its investors which is quite good.
| 6 Month Returns | 11.22% |
| 1 Year’s Returns | 6.00% |
| 5 Year’s Returns | 173.41% |
| Sales growth 3 Years | 12.6 % |
| Sales growth 5 Years | 11.5 % |
| Return over 3 Years | 14.8 % |
| Return over 5 Years | 22.2 % |
Alkem Share Price Target 2025-2030
| Year | Target 1 | Target 2 |
| 2025 | ₹7000 | ₹8000 |
| 2026 | ₹8000 | ₹10000 |
| 2027 | ₹10000 | ₹12000 |
| 2028 | ₹12000 | ₹15000 |
| 2029 | ₹15000 | ₹18000 |
| 2030 | ₹18000 | ₹22000 |
Alkem Share Price Target 2025
Talking about the Alkem Share Price Target 2025, our analysis has said that this stock can remain between ₹ 7,000 and ₹ 8,000 in 2025.
These targets are given after looking at the data of the past history of the stock. In this, fundamental analysis has been done along with technical analysis.
| Target 1 | Target 2 |
| ₹ 7,000 | ₹ 8,000 |
Alkem Share Price Target 2026
If the demand in this industry and the sales of this company see an increase, then as per our research the share price of Alkem Laboratories Ltd may remain between ₹ 8,000 and ₹ 10,000 by 2026.
| Target 1 | Target 2 |
| ₹ 8,000 | ₹ 10,000 |
Read this also:- Finolex Industries Share Price Target
Alkem Share Price Target 2027
These share targets have been derived by looking at the company’s past performance. If the company’s performance remains good, then according to our analysts, the target for Alkem shares in 2027 can be between ₹ 10,000 and ₹ 12,000.
| Target 1 | Target 2 |
| ₹ 10,000 | ₹ 12,000 |
Alkem Share Price Target 2028
By analyzing the trend and stock of the last few years, it is known that if we talk about the target of Alkem share price in 2028, then it can be between ₹12,000 and ₹15,000.
| Target 1 | Target 2 |
| ₹ 12,000 | ₹ 15,000 |
Alkem Share Price Target 2029
Looking at the history of the last 5 years and the fundamental analysis of the stock, it seems that in the coming years i.e. if we talk about the target of Alkem Share in 2029, then ₹15,000 and ₹18,000 can be seen.
| Target 1 | Target 2 |
| ₹15,000 | ₹18,000 |
Alkem Share Price Target 2030
The price of Alkem stock can remain between ₹ 18,000 to ₹ 22,000 by 2030. This price can also go up or down, this price is told by analyzing the stock data of the last 5 years.
The price of the company’s stock depends on how the company performs in the coming time. You must take the help of your financial advisor before investing.
| Target 1 | Target 2 |
| ₹ 18,000 | ₹ 22,000 |
Alkem Promoters Holding
Friends, before investing in any company, it is very important to see the holding of the company’s promoters because from this we get an idea that if the promoters of the company have maintained their holding and are not selling it, then the company is performing well and can perform well.
It is said that it is not good if promoter’s holding is less in any company but it is said that if the holdings of FIIs and DIIs are increasing then it is good.
If we talk about the promoters’ holding in this company, it is 55.66%. You will see below who else has a stake in it.
| Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
| Promoters | 57.13% | 57.16% | 56.74% | 55.66% |
| FIIs | 5.41% | 4.44% | 9.11% | 9.02% |
| DIIs | 14.14% | 16.69% | 15.63% | 19.21% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 23.32% | 21.69% | 18.51% | 16.12% |
Alkem Peer Companies
- Sun Pharma.Inds.
- Cipla
- Mankind Pharma
- Dr Reddy’s Labs
- Lupin
- Zydus Lifesci.
- Aurobindo Pharma
- Alkem Lab
Conclusion
We hope that you have got all the information about Alkem Share Price Target 2025, 2026, 2027, To 2030 properly and how did you like our blog, please tell us by commenting and also tell us what are your thoughts about Alkem Laboratories Ltd. Do share this article with your friends.
Frequently Asked Questions FAQ’S
How much debt does Alkem Laboratories have?
As of today when we are posting this blog, Alkem Laboratories has a debt of ₹ 1,478 Cr.
What does Alkem Laboratories Ltd do?
Alkem Laboratories operates in the pharmaceutical business with global operations. The company is engaged in the development, manufacturing and sale of pharmaceutical and nutraceutical products.
Disclaimer : The information presented in this article is for educational and informational purposes only. We do not recommend buying or selling stocks. These predictions are based on our research and technical data, any uncertainty in the market may affect the stock price, so investors should do their own research before making investment decisions. We will not be responsible for any loss or damage caused by the use of this article.